Health Check How Prudently Does EyeGene Use Debt - Simply Wall St

185490 Stock  KRW 2,825  5.00  0.18%   
About 62% of EyeGene's investor base is looking to short. The analysis of current outlook of investing in EyeGene suggests that many traders are alarmed regarding EyeGene's prospects. The current market sentiment, together with EyeGene's historical and current headlines, can help investors time the market. In addition, many technical investors use EyeGene stock news signals to limit their universe of possible portfolio assets.
  
Health Check How Prudently Does EyeGene Use Debt Simply Wall St

Read at news.google.com
Google News at Macroaxis
  

EyeGene Fundamental Analysis

We analyze EyeGene's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of EyeGene using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of EyeGene based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Current Ratio

Current Ratio Comparative Analysis

EyeGene is currently under evaluation in current ratio category among its peers. Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.

EyeGene Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with EyeGene stock to make a market-neutral strategy. Peer analysis of EyeGene could also be used in its relative valuation, which is a method of valuing EyeGene by comparing valuation metrics with similar companies.

Complementary Tools for EyeGene Stock analysis

When running EyeGene's price analysis, check to measure EyeGene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EyeGene is operating at the current time. Most of EyeGene's value examination focuses on studying past and present price action to predict the probability of EyeGene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EyeGene's price. Additionally, you may evaluate how the addition of EyeGene to your portfolios can decrease your overall portfolio volatility.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments